CAS
LMAT icon

Coppell Advisory Solutions’s LeMaitre Vascular LMAT Stock Holding History

Coppell Advisory Solutions’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-437
Closed -$40.6K – 1185
2024
Q4 		$40.6K Sell
437
-245
-36% -$23.6K 0.01% 652
2024
Q3 		$62.5K Sell
682
-28
-4% -$2.43K 0.01% 498
2024
Q2 		$58.4K Buy
+710
New +$52.2K 0.01% 456
2023
Q4 		$24.8K Buy
+437
New +$22.9K ﹤0.01% 670

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Coppell Advisory Solutions's LMAT Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 437 shares — an estimated $40.6K sold.

Coppell Advisory Solutions first reported a position in LMAT in Q4 2023 and held it in 4 quarters. The position peaked at $62.5K in Q3 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 437 LeMaitre Vascular shares in Q1 2025, an estimated $40.6K.
  • Coppell Advisory Solutions first reported a position in LeMaitre Vascular in Q4 2023 and held it in 4 quarters.
  • Coppell Advisory Solutions's LeMaitre Vascular position peaked at $62.5K in Q3 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.